Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-23-011726
Filing Date
2023-03-31
Accepted
2023-03-31 20:29:20
Documents
1
Period of Report
2023-03-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4070
  Complete submission text file 0001127602-23-011726.txt   5515
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Lofton Kevin E (Reporting) CIK: 0001468818 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 23790043